CA2674259A1 - Procedes permettant de detecter les anomalies de methylation des genes exprimes dans le cerveau ayant un effet sur le chromosome x pour diagnostiquer des troubles du spectre autistique - Google Patents

Procedes permettant de detecter les anomalies de methylation des genes exprimes dans le cerveau ayant un effet sur le chromosome x pour diagnostiquer des troubles du spectre autistique Download PDF

Info

Publication number
CA2674259A1
CA2674259A1 CA 2674259 CA2674259A CA2674259A1 CA 2674259 A1 CA2674259 A1 CA 2674259A1 CA 2674259 CA2674259 CA 2674259 CA 2674259 A CA2674259 A CA 2674259A CA 2674259 A1 CA2674259 A1 CA 2674259A1
Authority
CA
Canada
Prior art keywords
genes
chromosome
test
gene
autism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2674259
Other languages
English (en)
Inventor
Roger E. Stevenson
Julie R. Jones
Cindy D. Skinner
Michael J. Friez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GREENWOOD GENETIC CENTER Inc
Original Assignee
GREENWOOD GENETIC CENTER Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GREENWOOD GENETIC CENTER Inc filed Critical GREENWOOD GENETIC CENTER Inc
Priority to CA 2674259 priority Critical patent/CA2674259A1/fr
Publication of CA2674259A1 publication Critical patent/CA2674259A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
CA 2674259 2009-07-29 2009-07-29 Procedes permettant de detecter les anomalies de methylation des genes exprimes dans le cerveau ayant un effet sur le chromosome x pour diagnostiquer des troubles du spectre autistique Abandoned CA2674259A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2674259 CA2674259A1 (fr) 2009-07-29 2009-07-29 Procedes permettant de detecter les anomalies de methylation des genes exprimes dans le cerveau ayant un effet sur le chromosome x pour diagnostiquer des troubles du spectre autistique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2674259 CA2674259A1 (fr) 2009-07-29 2009-07-29 Procedes permettant de detecter les anomalies de methylation des genes exprimes dans le cerveau ayant un effet sur le chromosome x pour diagnostiquer des troubles du spectre autistique

Publications (1)

Publication Number Publication Date
CA2674259A1 true CA2674259A1 (fr) 2011-01-29

Family

ID=43514007

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2674259 Abandoned CA2674259A1 (fr) 2009-07-29 2009-07-29 Procedes permettant de detecter les anomalies de methylation des genes exprimes dans le cerveau ayant un effet sur le chromosome x pour diagnostiquer des troubles du spectre autistique

Country Status (1)

Country Link
CA (1) CA2674259A1 (fr)

Similar Documents

Publication Publication Date Title
US8367417B2 (en) Methods for determining dysregulation of methylation of brain expressed genes on the X chromosome to diagnose autism spectrum disorders
ES2965036T3 (es) Detección de aneuploidías cromosómicas fetales usando regiones de ADN que están metiladas diferencialmente entre el feto y la mujer embarazada
US20200071764A1 (en) Compositions and methods for detecting predisposition to a substance use disorder
Rosenberg et al. Effects of moderate drinking during pregnancy on placental gene expression
US8173369B2 (en) Peripheral gene expression biomarkers for autism
KR20220153109A (ko) Rnaset2를 통한 염증성 장 질환의 진단 방법
Bittel et al. Whole genome microarray analysis of gene expression in Prader–Willi syndrome
US20230304094A1 (en) Genomic alterations associated with schizophrenia and methods of use thereof for the diagnosis and treatment of the same
EP2723902A1 (fr) Traitement et diagnostic de troubles et d'états pathologiques épigénétiques
Hu et al. Association between the SIRT1 mRNA expression and acute coronary syndrome
Nectoux et al. Cell cloning‐based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes
CA2441086A1 (fr) Identification des alterations de l'expression genetique qui accompagnent le processus de vieillissement des mammiferes
Kobayashi et al. DNA methylation changes between relapse and remission of minimal change nephrotic syndrome
US20070141577A1 (en) Method
WO2017082943A1 (fr) Articles servant à diagnostiquer une fibrose hépatique
Aref-Eshghi et al. Epigenomic mechanisms of human developmental disorders
CA2674259A1 (fr) Procedes permettant de detecter les anomalies de methylation des genes exprimes dans le cerveau ayant un effet sur le chromosome x pour diagnostiquer des troubles du spectre autistique
Saxena et al. Functional analysis of DNMT1 SNPs (rs2228611 and rs2114724) associated with schizophrenia
Xu et al. Functional variants of TNFAIP3 are associated with systemic lupus erythematosus in a cohort of Chinese Han population
Saxena et al. Research Article Functional Analysis of DNMT1 SNPs (rs2228611 and rs2114724) Associated with Schizophrenia
Jacobsen DNA methylation and microRNA-mediated regulation of gene expression in adolescent Chronic Fatigue Syndrome
YUEN et al. GENOME-WIDE MAPPING
Yuen Epigenetics of human fetal and placental development
van Eijsden Microarray analysis of oxidative phosphorylation disorders
EP3234603A1 (fr) Articles servant à diagnostiquer une fibrose hépatique

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140725

FZDE Dead

Effective date: 20170321